Open original FDA record ↗Recall record
- FDA identifier
- Z-0325-2027
- Company in FDA record
- Artivion, Inc
- FDA classification date
- Oct 30, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Class II
Reason stated in the source
A cryopreserved pulmonary human cardiac patch, taken from a 64-year-old human donor, was outside the cardiac tissue donor age specification of newborn to 60 years. The patch was implanted, and due to limitations of long-term in vivo data, the possibility of premature graft dysfunction cannot be excluded.
Source facts
- Action
- On 9/18/2026, the notification was delivered via mail to customer who was advised of the following: Available biomechanical and histological evidence does not indicate an increased risk that would warrant additional patient testing, enhanced clinical monitoring, or other clinical intervention beyond the patient's routine standard of care. Accordingly, prophylactic removal or surgical replacement of the already implanted tissue solely because of the donor-age nonconformance is not clinically warranted. Complete and return the response form via email to fieldassurance@artivion.com Firm requests that any observed deficiency, performance concern, or other issue potentially associated with the tissue be reported to them vial email: fieldassurance@artivion.com or phone: +1-770-419-3355
- Initiated
- 2026-09-18
- Root cause
- Nonconforming Material/Component
- Distribution
- US Nationwide distribution in the state of IL.
- Recall number
- Z-0325-2027
- Recall status
- Open, Classified
- CDRH record ID
- 223129
- FDA classified
- 2026-10-30
- Recall event number
- 100012